#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Non-small cell lung cancer metastatic Arterial disorder SAPHO syndrome Retinopathy proliferative Dupuytren's contracture Fabry's disease Muscular dystrophy Gastrointestinal disorder Juvenile idiopathic arthritis VEXAS syndrome Oesophageal squamous cell carcinoma stage III Mantle cell lymphoma stage IV Henoch-Schonlein purpura Mucous membrane pemphigoid Hereditary ataxia More trials…

    Learn about Rare Diseases

    Thrombotic thrombocytopenic purpura – Diagnostics Rhabdomyosarcoma recurrent – Diagnostics Optic glioma – Diagnostics Mantle cell lymphoma stage II – Life with Disease Lennox-Gastaut syndrome – Basic Information Marginal zone lymphoma refractory – Diagnostics X-linked lymphoproliferative syndrome – Treatment Hereditary optic atrophy – Treatment Mantle cell lymphoma stage IV – Basic Information Retinitis pigmentosa More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dazucorilant Pyrazinamide Fluorescein Sodium Fasudil Hydrochloride Dnth103 Ciclosporin Antithymocyte Immunoglobulin 18F-Psma-1007 Clemastine Fumarate Ubamatamab FG001 Acenocoumarol Betula Verrucosa Pollen Trimetazidine Dihydrochloride PRT3789 SAR444336 Pegvaliase L-Lysine Acetate Magnesium Sulfate Heptahydrate Hydroxocobalamin More therapies…

    Learn about Your Condition

    Cardiac disorder Loeys-Dietz syndrome Eclampsia Radiation skin injury Glomerulonephritis chronic Haemofiltration Systemic scleroderma Skin papilloma Peptostreptococcus infection Critical illness Polyneuropathy Adrenogenital syndrome Atopic keratoconjunctivitis Pulmonary embolism Right ventricular dysfunction More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Cliniques Universitaires Saint-Luc

Cliniques Universitaires Saint-Luc

Hippokrateslaan 10, Batiment 54, Woluwe-Saint-Lambert, 1200, Belgium

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Volixibat for Treating Itching in Patients with Primary Sclerosing Cholangitis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Cholangitis sclerosing
    Investigated Drugs:
    • Volixibat
    Belgium France Germany Italy The Netherlands Spain

  • Study Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Stage II-IV Melanoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Pembrolizumab
    • Vibostolimab
    Austria Belgium France Germany Ireland Italy +3

  • Study on the Safety and Effectiveness of SerpinPC for Patients with Severe Hemophilia A or B

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Haemophilia A with anti factor VIII
    • Haemophilia A without inhibitors
    • Haemophilia B without inhibitors
    Belgium Bulgaria France Germany Italy Poland +1

  • Study on Radiotherapy with Xevinapant or Placebo for Older Patients with Advanced Head and Neck Cancer

    Not recruiting

    2 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Xevinapant
    Belgium France Germany Ireland Italy The Netherlands +3

  • Study on GEN1046 and Pembrolizumab for Patients with Advanced Endometrial Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Endometrial cancer
    Investigated Drugs:
    • Gen1046
    • Pembrolizumab
    Belgium Denmark Italy Poland Spain

  • Study on the Effectiveness of Ompenaclid with FOLFIRI and Bevacizumab for Patients with Advanced or Metastatic Colorectal Cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    • Colorectal cancer
    Investigated Drugs:
    • Rgx-202
    • Folinic Acid
    • Bevacizumab
    Belgium France Spain

  • Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Clopidogrel
    • Milvexian
    • Prasugrel
    Austria Belgium Bulgaria Croatia Czechia Denmark +14

  • Study on Volixibat for Treating Itching in Patients with Primary Biliary Cholangitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Primary biliary cholangitis
    Investigated Drugs:
    • Volixibat
    Belgium France Germany Italy The Netherlands Spain

  • Study on Ustekinumab for Children with Moderate to Severe Ulcerative Colitis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Ustekinumab
    Belgium Germany Hungary Poland

  • Study on the Safety and Effects of BIIB080 for Patients Aged 50-80 with Mild Cognitive Impairment or Mild Alzheimer’s Disease Dementia

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Florbetaben (18F)
    • Flutemetamol (18F)
    Belgium Czechia Denmark Finland France Germany +5
Previous Page
1 … 62 63 64 65 66 67
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!